뉴스
- Mifegyne Approval Hopes Lift Hyundai Pharm and Daehwa [K-Bio Pulse] South Korea’s pharmaceutical and life sciences sectors broadly declined on July 14.The pharmaceutical sector index fell 2.33% from the previous trading se
- Peptron Sinks on Fading Lilly Hopes; Nature Cell, BL Pharmtech Hit Limit-Up [K-Bio Pulse] On July 9, South Korean pharmaceutical and biotech stocks saw sharply divergent moves, with Nature Cell and BL Pharmtech both hitting the daily upper limit, whi
- HLB Jumps on FDA Review Hopes...Seers Rznomics Rally[K-Bio Pulse] On June 16, South Korea’s pharmaceutical and biotechnology stocks traded largely on company-specific catalysts, including regulatory expectations, busines
- Policy Hopes Drive 30% Surge in JW Pharma[K-bio Pulse] Government plans to review health insurance reimbursement for hair-loss treatments triggered sharp moves in Korea’s pharmaceutical and biotech sector on J
- Cg MedTech Hits Limit Up...Hair Loss Stocks Rally on Insurance Coverage Hopes [K-Bio Pulse] On June 19, Shares of South Korean medical device maker Cg MedTech surged to the daily upper limit on Thursday after reports emerged that its parent company, re